Search

Hutchison China MediTech Ltd ADR

Abrir

SetorSaúde

11.99 0.25

Visão Geral

Variação de preço das ações

24h

Atual

Mín

11.24

Máximo

12.01

Indicadores-chave

By Trading Economics

Rendimento

-8.9M

-8M

Vendas

3.7M

139M

P/E

Médio do Setor

121.2

56.659

Margem de lucro

-5.724

Funcionários

1,790

EBITDA

18M

4M

Recomendações

By TipRanks

Recomendações

Comprar

Previsão para 12 meses

+23.76% upside

Estatísticas de Mercado

By TradingEconomics

Capitalização de Mercado

195M

2.1B

Abertura anterior

11.74

Fecho anterior

11.99

Sentimento de Notícias

By Acuity

100%

0%

324 / 340 Ranking em Healthcare

Hutchison China MediTech Ltd ADR Gráfico

O desempenho passado não é um indicador confiável de resultados futuros.

Notícias Relacionadas

1 de set. de 2026, 23:56 UTC

News

Wix.com Ltd faces a securities class action lawsuit over alleged false statements about its AI products, leading shares to trade lower in after-market hours.

1 de set. de 2026, 23:56 UTC

News

AbbVie Inc. has filed for a new Skyrizi regimen to treat Crohn's disease. Shares are lower in after-market hours amid broader market pressure from rising oil prices.

1 de set. de 2026, 23:51 UTC

News

Telephone and Data Systems withdraws Array Digital Infrastructure acquisition proposal and resumes share repurchase program. Shares rise in after-market trading.

1 de set. de 2026, 23:51 UTC

News
Correlated Moves

EOG Resources shares are higher after the company announced participation in the Barclays Energy-Power Conference, with oil prices surpassing $90 per barrel.

1 de set. de 2026, 23:46 UTC

News
Correlated Moves

Biontech SE's shares are lower in after-market hours following a decline in Moderna and amid ongoing challenges, including a halted cancer trial.

1 de set. de 2026, 23:46 UTC

News

Hormel Foods Corp will participate in the 2026 Barclays Global Consumer Staples Conference. Shares are trading higher during after-market hours following the announcement.

1 de set. de 2026, 23:41 UTC

News

StoneX Group Inc shares are lower in after-market hours, reflecting broader market concerns over rising oil prices and ongoing inflation fears amid recent negative trends.

1 de set. de 2026, 23:41 UTC

News

Carrier Global shares are higher in after-market trading ahead of the Morgan Stanley conference on September 15, 2026, featuring CEO David Gitlin.

1 de set. de 2026, 23:41 UTC

News
Correlated Moves

ONEOK Inc's shares are higher in after-market trading following several rating adjustments, including price target increases from Scotiabank and Morgan Stanley.

1 de set. de 2026, 23:41 UTC

News

Dropbox shares fell in after-market hours following a Bloomberg report on a data breach affecting about 5,000 user accounts.

1 de set. de 2026, 23:36 UTC

News

G-III Apparel Group has acquired the Marc Jacobs brand from LVMH. Shares are trading higher in after-market hours following the announcement.

1 de set. de 2026, 23:36 UTC

News

Quest Diagnostics has signed a multi-year agreement with Renalytix PLC for kidneyintelX.dkd testing, contributing to a modest rise in shares during after-market hours.

1 de set. de 2026, 23:31 UTC

News
Social Media

PBF Energy shares advanced in after-market trading following the release of its 2025 Sustainability Data Supplement, amid rising crude oil prices above $90.

1 de set. de 2026, 23:31 UTC

News
Correlated Moves
Social Media

Hong Kong's Exchange Fund fell to HK$4.404 trillion in July, with CAD/HKD trading lower amid rising crude oil prices and inflation concerns.

1 de set. de 2026, 23:26 UTC

News

Shareholders approve increase of authorized shares to 135 million.

1 de set. de 2026, 23:26 UTC

News

Tencent Music Entertainment shares are lower in after-market hours following a proposed public offering of senior unsecured notes for refinancing and share repurchases.

1 de set. de 2026, 23:21 UTC

News

Enovix Corp's drone battery portfolio is now TAA-compliant, boosting its U.S. defense supply chain position. Shares are lower in after-market trading amid broader market trends.

1 de set. de 2026, 23:21 UTC

News

Lamar Advertising Co declared a quarterly cash dividend of $1.65 per share, up from $1.60, as shares traded lower in after-market hours.

1 de set. de 2026, 23:16 UTC

News

BridgeBio Pharma shares are lower in after-market hours following a $500 million mixed securities shelf filing, raising concerns about potential dilution.

1 de set. de 2026, 23:16 UTC

News

Emerson Electric is trading higher in after-market hours following multiple analyst rating adjustments and price target changes from various firms.

1 de set. de 2026, 23:16 UTC

News

Adecoagro SA completed the R$705 million acquisition of Caarapó Mill, enhancing operations in Mato Grosso do Sul. Shares are trading higher after the announcement.

1 de set. de 2026, 23:16 UTC

News

ResMed Inc has initiated a $450 million accelerated share repurchase agreement, contributing to higher shares in after-market trading. Final settlement is set for December 2026.

1 de set. de 2026, 23:16 UTC

News

SoFi Technologies Inc shares rose in after-market hours following Scotiabank's initiation of coverage with a Sector Outperform rating and a price target of $25.00.

1 de set. de 2026, 23:16 UTC

News
Social Media

Palantir Technologies' subsidiary secured a prime contract with the Army for eight TITAN ground station systems, boosting shares slightly higher in after-hours trading.

1 de set. de 2026, 23:16 UTC

News
Correlated Moves
Social Media

CHF/HKD declines amid geopolitical tensions and a decrease in Hong Kong's Exchange Fund assets, which fell to HK$4.404 trillion at July's end.

1 de set. de 2026, 23:06 UTC

News
Social Media

Snowflake shares are higher in after-market trading as discussions on social media build ahead of its earnings report, with revenue expectations at $1.48 billion.

1 de set. de 2026, 23:06 UTC

News

Union Pacific shares are lower in after-market trading, amid rising oil prices and inflation concerns, despite updates on its merger with Norfolk Southern.

1 de set. de 2026, 23:06 UTC

News

Sprouts Farmers Market shares fell in after-hours trading following the announcement of a leadership transition, with Nick Konat set to become CEO in January 2027.

1 de set. de 2026, 23:06 UTC

News
Correlated Moves
Social Media

The USD/DKK is trading higher as rising oil prices raise inflation concerns amid geopolitical tensions in the Middle East.

1 de set. de 2026, 23:06 UTC

News
Social Media

Alphabet Inc. shares rose in after-hours trading on positive sentiment surrounding its upcoming AI model, Gemini 3.8 Flash, expected to enhance coding capabilities.

Comparação entre Pares

Variação de preço

Hutchison China MediTech Ltd ADR Previsão

Preço-alvo

By TipRanks

23.76% parte superior

Previsão para 12 meses

Média 15 USD  23.76%

Máximo 16 USD

Mínimo 14 USD

Com base em 2 analistas de Wall Street que oferecem metas de preço de 12 meses para Hutchison China MediTech Ltd ADR - Dist nos últimos 3 meses.

Consenso de Avaliação

By TipRanks

Comprar

2 ratings

1

Comprar

1

Manter

0

Vender

Informação Financeira

Custos administrativos e de venda

Custos Operacionais

Lucro antes de imposto

Vendas

Custo das vendas

Lucro bruto sobre vendas

Despesa com juros da dívida

EBITDA

Resultado Operacional

$

Sobre Hutchison China MediTech Ltd ADR

HUTCHMED (China) Limited, together with its subsidiaries, discovers, develops, and commercializes targeted therapeutics and immunotherapies for cancer and immunological diseases in Hong Kong and internationally. The company develops Savolitinib for the treatment of non-small cell lung cancer (NSCLC), papillary renal cell carcinoma (RCC), and gastric cancer (GC); and Fruquintinib, an inhibitor for colorectal cancer (CRC), breast cancer, gastric cancer, microsatellite stable-CRC endometrial cancer (EMC), NSCLC, RCC, gastrointestinal, cervical, and solid tumors. It also develops Surufatinib, which is used for the treatment of pancreatic neuroendocrine tumor (NET), non-pancreatic NET, neuroendocrine carcinoma, SCLC, biliary tract cancer, and solid tumors; and Sovleplenib that treats hematological cancers and certain chronic immune diseases. In addition, it develops Tazemetostat for the treatment of certain epithelioid sarcoma and follicular lymphoma patients; HMPL-306, an inhibitor for hematological malignancies, gliomas, chondrosarcomas, cholangiocarcinomas, and solid tumors; HMPL-760, a Bruton's tyrosine kinase inhibitor; HMPL-453 for intrahepatic cholangiocarcinoma and solid tumors; HMPL-295 and HMPL-415 for solid tumors; HMPL-653 for metastatic solid tumors and tenosynovial giant cell tumors; and HMPL-A83 for the treatment of malignant neoplasms. It has collaboration agreements with AstraZeneca AB (publ), Lilly (Shanghai) Management Company Limited, Takeda, BeiGene Ltd., Inmagene Biopharmaceuticals Co. Ltd., Innovent Biologics Co., Inc., Genor Biopharma Co. Ltd., Shanghai Junshi Biosciences Co. Ltd., and Epizyme, Inc. The company was formerly known as Hutchison China MediTech Limited and changed its name to HUTCHMED (China) Limited in May 2021. HUTCHMED (China) Limited was incorporated in 2000 and is headquartered in Hong Kong, Hong Kong.
help-icon Live chat